Suchergebnis | Hamburg Open Science

Facetten

27 Einträge gefunden

Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
2012 - Forschungsinformationssystem des UKE
The presence of prostate cancer on saturation biopsy can be accurately predicted.
2010 - Forschungsinformationssystem des UKE
Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study.
2009 - Forschungsinformationssystem des UKE
Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study.
2009 - Forschungsinformationssystem des UKE
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
2009 - Forschungsinformationssystem des UKE
Baseline prevalence of erectile dysfunction in a prostate cancer screening population.
2008 - Forschungsinformationssystem des UKE
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level
2008 - Forschungsinformationssystem des UKE
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
2008 - Forschungsinformationssystem des UKE
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
2008 - Forschungsinformationssystem des UKE
Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.
2008 - Forschungsinformationssystem des UKE
Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.
2008 - Forschungsinformationssystem des UKE
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.
2008 - Forschungsinformationssystem des UKE
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
2008 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
2008 - Forschungsinformationssystem des UKE
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
2008 - Forschungsinformationssystem des UKE
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
2007 - Forschungsinformationssystem des UKE
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
2007 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.

The presence of prostate cancer on saturation biopsy can be accurately predicted.

Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.

Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study.

Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study.

External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy.

Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.

Baseline prevalence of erectile dysfunction in a prostate cancer screening population.

Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level

Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.

External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.

Biopsies performed at tertiary care centers are superior to referral biopsies in predicting pathologic Gleason sum.

Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.

Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.

Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.

A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.

Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.